Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07362654 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease

Study acronym: CELLiomicS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Enrollment increased: 45 → 51 participants
    • Study description expanded, about 19 words
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study investigates how the immune system of children with celiac disease responds to controlled, small amounts of gluten. Children on a strict gluten-free diet are randomly assigned to receive either placebo, 50 mg of gluten, or 5 g of gluten once daily for three days, simulating real-life accidental exposure or dietary transgression. Blood samples are collected on Day 1 (before gluten intake) and Day 8 (five days after the last dose). Stool and urine samples are also collected for complementary analyses. Using single-cell ribonucleic acid (RNA) sequencing, T-cell receptor sequencing, microRNA profiling, and exploratory metabolomics, the study aims to characterize changes in immune cell populations and gene expression after gluten exposure. The objective is to determine whether even very small amounts of gluten induce measurable systemic immune responses and whether these responses differ according to the dose administered. Understanding these mechanisms may support the development of new biomarkers and improve clinical management of pediatric celiac disease.
Trial Details
NCT Number NCT07362654
Lead Sponsor Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
Collaborators: Hospital Regional de Malaga, Andaluz Health Service, Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental, Universidad de Málaga, Consorcio Centro de Investigación Biomédica en Red (CIBER), Biohealth Research Institute in Granada (ibs.GRANADA)
Conditions
(from sponsor)
Celiac Disease, Gluten Sensitivity, Autoimmune Diseases
Related terms Autoimmune Diseases, Celiac Disease
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov